Related Experiment Video
Updated: Feb 20, 2026
Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors
Published on: July 17, 2020
Cell Density Affects the Detection of Chk1 Target Engagement by the Selective Inhibitor V158411
Clara C Geneste1, Andrew J Massey1
11 Vernalis Research, Cambridge, UK.
Abstract:
Understanding drug target engagement and the relationship to downstream pharmacology is critical for drug discovery. Here we have evaluated target engagement of Chk1 by the small-molecule inhibitor V158411 using two different target engagement methods (autophosphorylation and cellular thermal shift assay [CETSA]). Target engagement measured by these methods was subsequently related to Chk1 inhibitor-dependent pharmacology. Inhibition of autophosphorylation was a robust method for measuring V158411 Chk1 target engagement. In comparison, while target engagement determined using CETSA appeared robust, the V158411 CETSA target engagement EC50 values were 43- and 19-fold greater than the autophosphorylation IC50 values. This difference was attributed to the higher cell density in the CETSA assay configuration. pChk1 (S296) IC50 values determined using the CETSA assay conditions were 54- and 33-fold greater than those determined under standard conditions and were equivalent to the CETSA EC50 values. Cellular conditions, especially cell density, influenced the target engagement of V158411 for Chk1. The effects of high cell density on apparent compound target engagement potency should be evaluated when using target engagement assays that necessitate high cell densities (such as the CETSA conditions used in this study). In such cases, the subsequent relation of these data to downstream pharmacological changes should therefore be interpreted with care.
Insights
Evaluating Chk1 inhibitor V158411 target engagement revealed that high cell density in assays like CETSA can significantly alter potency measurements, impacting downstream pharmacology interpretation.
Area of Science:
- Pharmacology
- Biochemistry
- Drug Discovery
Background:
- Drug target engagement is crucial for drug discovery and development.
- Understanding the relationship between target engagement and downstream pharmacology is essential.
Purpose of the Study:
- To evaluate Chk1 target engagement by V158411 using autophosphorylation and CETSA methods.
- To investigate the impact of cellular conditions, specifically cell density, on target engagement measurements.
Main Methods:
- Utilized autophosphorylation inhibition and Cellular Thermal Shift Assay (CETSA) to measure Chk1 target engagement.
- Related target engagement data to Chk1 inhibitor-dependent pharmacology.
Main Results:
- Autophosphorylation inhibition proved a robust method for assessing V158411 Chk1 engagement.
- CETSA showed robust target engagement but yielded EC50 values 43- and 19-fold greater than autophosphorylation IC50 values.
- Higher cell density in CETSA assays inflated apparent potency for both target engagement and downstream pChk1 inhibition.
Conclusions:
- Cellular conditions, particularly cell density, significantly influence apparent target engagement potency.
- High cell density effects on target engagement potency must be considered for assays like CETSA.
- Interpretation of downstream pharmacology data requires careful consideration of assay conditions, especially cell density.
